ValiRx plc (LON:VAL – Get Free Report)’s share price traded up 22.8% during trading on Wednesday . The stock traded as high as GBX 0.18 and last traded at GBX 0.18. 33,947,781 shares changed hands during mid-day trading, an increase of 221% from the average session volume of 10,563,343 shares. The stock had previously closed at GBX 0.14.
ValiRx Stock Performance
The company has a fifty day moving average price of GBX 0.19 and a two-hundred day moving average price of GBX 0.28. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.62 and a quick ratio of 1.27. The company has a market capitalization of £2.35 million, a P/E ratio of -0.33 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The business had revenue of GBX 3 million for the quarter. Equities analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
- 2 Quantum Stocks That Could Challenge IonQ’s Leadership
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
